Broadfin Capital discloses updated portfolio positions in 13F filing: New stakes in ARLZ, CSII; Closes positions in AMAG, AMPH, BLRX, ATRC, BIOD, GNCA
Highlights from 2016 Q1 filing as compared to 2015 Q4 filing:
- New positions in: ARLZ (~3.8 mln shares) CSII (~1.5 mln)
- Increased positions in: RPTP (to ~7 mln shares from ~2.4 mln shares) CPRX (to ~8.2 mln from ~4.2 mln)
- Decreased positions in: CRDC (to ~0.9 mln shares from ~8.9 mln shares)
- Closed positions in: AMAG (from ~0.3 mln shares), AMPH (from ~1 mln), ATRC (from ~0.8 mln), BLRX (from ~3.5 mln), BIOD (from ~2 mln), GNCA (from ~0.8 mln)